Mechanism of action of angiostatic steroids: Suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis
Autor: | Daniel B. Rifkin, Wilson El, F. Blei, Paolo Mignatti |
---|---|
Rok vydání: | 1993 |
Předmět: |
medicine.medical_specialty
Proteases Hydrocortisone Physiology Plasmin Angiogenesis Clinical Biochemistry Basic fibroblast growth factor Medroxyprogesterone Acetate Biology Dexamethasone Plasminogen Activators chemistry.chemical_compound Internal medicine Plasminogen Activator Inhibitor 1 Hydroxyprogesterones medicine Animals Aorta Cells Cultured Neovascularization Pathologic Heparin 17-alpha-Hydroxyprogesterone Biological activity Cell Biology Urokinase-Type Plasminogen Activator Endothelial stem cell Endocrinology chemistry Cell culture Cattle Fibroblast Growth Factor 2 Steroids Endothelium Vascular Plasminogen activator medicine.drug |
Zdroj: | Journal of Cellular Physiology. 155:568-578 |
ISSN: | 1097-4652 0021-9541 |
DOI: | 10.1002/jcp.1041550315 |
Popis: | Recently, a novel class of angiostatic steroids which block angiogenesis in several systems has been described. Since the elaboration of proteases is believed to be an important component of angiogenesis, we tested whether these steroids blocked the fibrinolytic response of endothelial cells to the angiogenic protein, basic fibroblast growth factor [bFGF]). Cultured bovine aortic endothelial (BAE) cells were incubated with bFGF and/or medroxyprogesterone acetate (MPA), an angio-static steroid which has been shown to inhibit vascularization, collagenolysis, and tumor growth. When bFGF (3 ng/ml) was added to confluent monolayers of BAE cells, plasminogen activator (PA) activity in the medium was increased threefold. In contrast, MPA at 10−6 M, 10−7 M, 10−8 M, and 10−9 M decreased PA levels in the medium by 83%, 83%, 75%, and 39%, respectively. The stimulation of PA levels in BAE cells by bFGF (3 ng/ml) was abrogated by the presence of 10−6 M MPA. This decrease in PA activity was found to be mediated by a significant increase in plasminogen activator inhibitor type-1 (PAI-1) production. MPA, therefore, negated one of the important enzymatic activities associated with the angiogenic process. In contrast to the decreased levels of secreted PA in cultures exposed simultaneously to MPA and bFGF, cell-associated PA levels remained high, consistent with earlier observations indicating that PAI-1 does not inhibit cell-associated PA. Thus, angiostatic steroids may exert their inhibitory effects on angiogenesis by increasing the synthesis of PAI-1. This, in turn, inhibits PA activity and, therefore, plasmin generation, which is essential for the invasive aspect of angiogenesis. © 1993 Wiley-Liss, Inc. |
Databáze: | OpenAIRE |
Externí odkaz: |